Ultimately, none of the animal or cell culture models of AD or tau pathology, except for the APP and other similar beta amyloid overexpressing transgenic mice that were used to develop the first anti amyloid vaccine (AN1792), have been predictive of treatment effects in humans. The gene discussed is MAPT; the disease is Alzheimer disease.